Decisional Process in Male Fertility Preservation

NCT ID: NCT02411214

Last Updated: 2015-04-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

348 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-01-31

Study Completion Date

2014-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The survey analyses how to improve the decision-making process for fertility preservation in the pediatric population based on

1. patient and parent feelings about fertility preservation counselling
2. influence of the emotional state of patients and parents on fertility preservation acceptance
3. support of medical staff and family The study revealed that attention to the fertility preservation pathways was important for the satisfaction of patient's and parent's expectations

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Questionnaire survey via regular mail to an eligible population (boys and adolescents aged 0 to 18 years diagnosed with cancer at the Cliniques universitaires Saint Luc) between January 2005 and May 2013.

Three different questionnaires, for children (\<12 years and 12-18 years) and parents respectively, established based on information from focus groups and subsequently reviewed by the institutional ethics board before being sent.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Infertility Quality of Life Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

<12 years

children under 12 years diagnosed with cancer questionnaire survey

survey

Intervention Type OTHER

questionnaire survey sent by regular mail for 3 groups

12-18 years

adolescents diagnosed with cancer questionnaire survey

survey

Intervention Type OTHER

questionnaire survey sent by regular mail for 3 groups

parents

parents of children and adolescents diagnosed with cancer questionnaire survey

survey

Intervention Type OTHER

questionnaire survey sent by regular mail for 3 groups

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

survey

questionnaire survey sent by regular mail for 3 groups

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* prepubertal boys and adolescents diagnosed with cancer in a university hospital setting between january 2005 and may 2013

Exclusion Criteria

* none
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Wyns

Head of department gynecology-andrology

Responsibility Role PRINCIPAL_INVESTIGATOR

References

Explore related publications, articles, or registry entries linked to this study.

Wyns C, Collienne C, Shenfield F, Robert A, Laurent P, Roegiers L, Brichard B. Fertility preservation in the male pediatric population: factors influencing the decision of parents and children. Hum Reprod. 2015 Sep;30(9):2022-30. doi: 10.1093/humrep/dev161. Epub 2015 Jul 3.

Reference Type DERIVED
PMID: 26141713 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FP1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.